Peramivir — CAS 229614-55-5

Peramivir is a cyclopentane-based neuraminidase inhibitor used as an antiviral agent against influenza A and B infections. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. Peramivir is unique among neuraminidase inhibitors as it is administered intravenously, making it suitable for hospitalized patients and those unable to take oral or inhaled antivirals. It received FDA approval for treatment of acute uncomplicated influenza.

• Intravenous treatment of acute uncomplicated influenza A and B
• Severe or complicated influenza in hospitalized patients
• Influenza treatment in patients unable to take oral/inhaled antivirals
• Pandemic influenza preparedness stockpiling

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support